Cambium Bio Limited
CMB
Rank in Stocks
#32554
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Share Price
$0.31737816
Market Cap
$9.34M
Change (1 day)
0.00%
Change (1 year)
5,917.33%
Country
AU
Trade Cambium Bio Limited (CMB)
Category
Healthcare
Stock split history for Cambium Bio Limited (CMB)
Cambium Bio Limited stock (symbol: CMB) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One CMB share bought prior to Oct 21, 2026 would equal to 0 CMB shares today.
The most recent stock split occurred on Oct 21, 2026.
One CMB share bought prior to Oct 21, 2026 would equal to 0 CMB shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
